Global arbovirus initiative. World Health Organization https://iris.who.int/server/api/core/bitstreams/2a55ec8b-bbf5-46c9-a5bb-696f15196d49/content (2025).
Lim, A. et al. The overlapping global distribution of dengue, chikungunya, Zika and yellow fever. Nat. Commun. 16, 3418 (2025).
Zika virus disease. World Health Organization https://www.who.int/health-topics/zika-virus-disease/ (2025).
The history of Zika virus. World Health Organization https://www.who.int/news-room/feature-stories/detail/the-history-of-zika-virus/ (2016).
Duffy, M. R. et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N. Engl. J. Med. 360, 2536–2543 (2009).
Zika virus. World Health Organization https://www.who.int/news-room/fact-sheets/detail/zika-virus/ (2025).
Faria, N. R. et al. Zika virus in the Americas: early epidemiological and genetic findings. Science 352, 345–349 (2016).
Waddell, L. A. & Greig, J. D. Scoping review of the Zika virus literature. PLoS ONE 11, e0156376 (2016).
Musso, D., Ko, A. I. & Baud, D. Zika virus infection—after the pandemic. N. Engl. J. Med. 381, 1444–1457 (2019).
WHO statement on the first meeting of the International Health Regulations (2005) (IHR 2005) Emergency Committee on Zika virus and observed increase in neurological disorders and neonatal malformations (World Health Organization, 2016) https://www.who.int/news/item/01-02-2016-who-statement-on-the-first-meeting-of-the-international-health-regulations-(2005)-(ihr-2005)-emergency-committee-on-zika-virus-and-observed-increase-in-neurological-disorders-and-neonatal-malformations/
Haby, M. M., Pinart, M., Elias, V. & Reveiz, L. Prevalence of asymptomatic Zika virus infection: a systematic review. Bull. World Health Organ. 96, 402–413D (2018).
Zika virus disease contracted during travel: likely places of infection reported by travellers to the EU/EEA. European Centre for Disease Control https://www.ecdc.europa.eu/en/zika-virus-infection/surveillance-and-disease-data/travel-associated-cases/ (2025).
Pathogens prioritization: a scientific framework for epidemic and pandemic research preparedness. World Health Organization https://www.who.int/publications/m/item/pathogens-prioritization-a-scientific-framework-for-epidemic-and-pandemic-research-preparedness/ (2024).
2018 Annual review of diseases prioritized under the Research and Development Blueprint (World Health Organization, 2018) https://www.who.int/docs/default-source/blue-print/2018-annual-review-of-diseases-prioritized-under-the-research-and-development-blueprint.pdf
Priority pathogen families research and development (R&D) tool. UK Health Security Agency https://assets.publishing.service.gov.uk/media/67f5259ae3c60873d6c90d08/UKHSA-priority-pathogen-families-research-and-development-tool.pdf (2025).
Cuomo-Dannenburg, G. et al. Marburg virus disease outbreaks, mathematical models, and disease parameters: a systematic review. Lancet Infect. Dis. 24, e307–e317 (2024).
Nash, R. K. et al. Ebola virus disease mathematical models and epidemiological parameters: a systematic review. Lancet Infect. Dis.e762–e773 (2024).
Doohan, P. et al. Lassa fever outbreaks, mathematical models, and disease parameters: a systematic review and meta-analysis. Lancet Glob. Health 12, e1962–e1972 (2024).
Morgenstern, C. et al. Severe acute respiratory syndrome (SARS) mathematical models and disease parameters: a systematic review. Lancet Microbe 6, 101144 (2025).
Naidoo, T. et al. epireview: tools to update and summarise the latest pathogen data from the Pathogen Epidemiology Review Group (PERG). R package version 1.4.4 https://github.com/mrc-ide/epireview (2025).
Adekolu-John, E. O. & Fagbami, A. H. Arthropod-borne virus antibodies in sera of residents of Kainji Lake Basin, Nigeria 1980. Trans. R. Soc. Trop. Med. Hyg. 77, 149–151 (1983).
Lynn, M. K. et al. Perinatal dengue and Zika virus cross-sectional seroprevalence and maternal-fetal outcomes among El Salvadoran women presenting for labor-and-delivery. Matern. Health Neonatol. Perinatol. 10, 7 (2024).
Anaya, J. M. et al. A comprehensive analysis and immunobiology of autoimmune neurological syndromes during the Zika virus outbreak in Cucuta, Colombia. J. Autoimmun. 77, 123–138 (2017).
Borena, W. et al. No molecular or serological evidence of Zikavirus infection among healthy blood donors living in or travelling to regions where Aedes albopictus circulates. PLoS ONE 12, e0178175 (2017).
Ziyaeyan, M. et al. Widespread circulation of West Nile virus, but not Zika virus in southern Iran. PLoS Negl. Trop. Dis. 12, e0007022 (2018).
Chien, Y. et al. Low seroprevalence of Zika virus infection among adults in Southern Taiwan. BMC Infect. Dis. https://doi.org/10.1186/s12879-019-4491-4 (2019).
Alves, L., Leal, C. & Alves, J. Zika virus seroprevalence in women who gave birth during Zika virus outbreak in Brazil – a prospective observational study. Heliyon https://doi.org/10.1016/j.heliyon.2020.e04817 (2020).
Souza Gonçalves, M. et al. Prevalence of arboviruses in sickle cell disease patients from two different regions of Brazil, the North and Northeast. Braz. J. Infect. Dis. 28, 103741 (2024).
Saba Villarroel, P. M. et al. Zika virus epidemiology in Bolivia: a seroprevalence study in volunteer blood donors. PLoS Negl. Trop. Dis. 12, e0006239 (2018).
Chepkorir, E. et al. Serological evidence of Flavivirus circulation in human populations in Northern Kenya: an assessment of disease risk 2016–2017. Virol. J. https://doi.org/10.1186/s12985-019-1176-y (2019).
Putri, N. D. et al. Absence of evidence of Zika virus infection in cord blood and urine from newborns with congenital abnormalities, Indonesia. Am. J. Trop. Med. Hyg. 102, 876–879 (2020).
Ngo-Giang-Huong, N. et al. Lack of association between adverse pregnancy outcomes and Zika antibodies among pregnant women in Thailand between 1997 and 2015. Viruses https://doi.org/10.3390/v13081423 (2021).
Rodriguez-Barraquer, I. et al. Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region. Science 363, 607–610 (2019).
Périssé, A. R. S. et al. Zika, dengue and chikungunya population prevalence in Rio de Janeiro city, Brazil, and the importance of seroprevalence studies to estimate the real number of infected individuals. PLoS ONE 15, e0243239 (2020).
Kitro, A. et al. Seroprevalence of dengue, Japanese encephalitis and Zika among long-term expatriates in Thailand. J. Travel Med. https://doi.org/10.1093/jtm/taae022 (2024).
Yamanaka, A. et al. Seroprevalence of Flavivirus neutralizing antibodies in Thailand by High-throughput neutralization assay: endemic circulation of Zika virus before 2012. mSphere https://doi.org/10.1128/mSphere.00339-21 (2021).
Ushijima, Y. et al. Surveillance of the major pathogenic arboviruses of public health concern in Gabon, Central Africa: increased risk of West Nile virus and dengue virus infections. BMC Infect. Dis. 21, 265 (2021).
Ward, D. et al. Sero-epidemiological study of arbovirus infection following the 2015–2016 Zika virus outbreak in Cabo Verde. Sci. Rep. https://doi.org/10.1038/s41598-022-16115-4 (2022).
Rahman, M., Bekele-Maxwell, K., Cates, L., Banks, H. & Vaidya, N. Modeling Zika virus transmission dynamics: parameter estimates, disease characteristics, and prevention. Sci. Rep. https://doi.org/10.1038/s41598-019-46218-4 (2019).
Dantas, E., Tosin, M. & Cunha, A. Calibration of a SEIR-SEI epidemic model to describe the Zika virus outbreak in Brazil. Appl. Math Comput. 338, 249–259 (2018).
Tuncer, N., Marctheva, M., LaBarre, B. & Payoute, S. Structural and practical identifiability analysis of Zika epidemiological models. Bull. Math Biol. 80, 2209–2241 (2018).
Singapore Zika Study Group. Outbreak of Zika virus infection in Singapore: an epidemiological, entomological, virological, and clinical analysis. Lancet. Infect. Dis.17, 813–821 (2017).
Riou, J., Poletto, C. & Boelle, P. Y. A comparative analysis of Chikungunya and Zika transmission. Epidemics 19, 43–52 (2017).
Winokur, O., Main, B., Nicholson, J. & Barker, C. Impact of temperature on the extrinsic incubation period of Zika virus in Aedes aegypti. PLoS Negl. Trop. Dis. https://doi.org/10.1371/journal.pntd.0008047 (2020).
Lequime, S. et al. Modeling intra-mosquito dynamics of Zika virus and its dose-dependence confirms the low epidemic potential of Aedes albopictus. PLOS Pathog. https://doi.org/10.1371/journal.ppat.1009068 (2020).
Rojas, D. P. et al. The epidemiology and transmissibility of Zika virus in Girardot and San Andres island, Colombia, September 2015 to January 2016. Euro Surveill. https://doi.org/10.2807/1560-7917.es.2016.21.28.30283 (2016).
Angelo, K. et al. Zika among international travellers presenting to GeoSentinel sites, 2012–2019: implications for clinical practice. J. Travel Med. https://doi.org/10.1093/jtm/taaa061 (2020).
Schirmer, P. L. et al. Zika virus infection in the Veterans Health Administration (VHA), 2015–2016. PLoS Negl. Trop. Dis. 12, e0006416 (2018).
Hoen, B. et al. Pregnancy outcomes after ZIKV infection in French Territories in the Americas. N. Engl. J. Med. 378, 985–994 (2018).
Clemente, N. et al. Zika virus infection in pregnancy and adverse fetal outcomes in SAo Paulo State, Brazil: a prospective cohort study. Sci. Rep.https://doi.org/10.1038/s41598-020-69235-0 (2020).
Wongsawat, J. et al. Characteristics, risk factors, and outcomes related to Zika virus infection during pregnancy in Northeastern Thailand: a prospective pregnancy cohort study. PLoS Negl. Trop. Dis. 18, 2018–2020 (2024).
Marbán-Castro, E. et al. Zika virus infection in pregnant travellers and impact on childhood neurodevelopment in the first two years of life: A prospective observational study. Travel Med. Infect. Dis. https://doi.org/10.1016/j.tmaid.2021.101985 (2021).
Petrone, M. et al. Asynchronicity of endemic and emerging mosquito-borne disease outbreaks in the Dominican Republic. Nat. Commun. https://doi.org/10.1038/s41467-020-20391-x (2021).
Lannuzel, A. et al. Long-term outcome in neuroZika: when biological diagnosis matters. Neurology 92, e2406–e2420 (2019).
Cunha, A. J., de Magalhaes-Barbosa, M. C., Lima-Setta, F., Medronho, R. A. & Prata-Barbosa, A. Microcephaly case fatality rate associated with Zika virus infection in Brazil: current estimates. Pediatr. Infect. J. 36, 528–530 (2017).
Pereira, J. et al. The role of amniocentesis in the diagnosis of congenital Zika syndrome. Clin. Infect. Dis. 69, 713–716 (2019).
Charniga, K. et al. Descriptive analysis of surveillance data for Zika virus disease and Zika virus-associated neurological complications in Colombia, 2015–2017. PLoS ONE https://doi.org/10.1371/journal.pone.0252236 (2021).
Flamand, C. et al. The proportion of asymptomatic infections and spectrum of disease among pregnant women infected by Zika virus: systematic monitoring in French Guiana, 2016. Euro Surveill. https://doi.org/10.2807/1560-7917.es.2017.22.44.17-00102 (2017).
Aubry, M. et al. Zika virus seroprevalence, French Polynesia, 2014–2015. Emerg. Infect. Dis. 23, 669–672 (2017).
Melo, N. D. L., Sousa, D. F. D. & Laporta, G. Z. Microcephaly and associated risk factors in newborns: a systematic review and meta-analysis study. Trop. Med. Infect. Dis. 7, 261 (2022).
Nithiyanantham, S. F. & Badawi, A. Maternal infection with Zika virus and prevalence of congenital disorders in infants: systematic review and meta-analysis. Can. J. Public Health 110, 638–648 (2019).
Martins, M. M. et al. Fetal, neonatal, and infant outcomes associated with maternal Zika virus infection during pregnancy: a systematic review and meta-analysis. PLoS ONE 16, e0246643 (2021).
Coelho, A. & Crovella, S. Microcephaly prevalence in infants born to Zika Virus-infected women: a systematic review and meta-analysis. Int. J. Mol. Sci. 18, 1714 (2017).
Gallo, L. G. et al. Another piece of the Zika puzzle: assessing the associated factors to microcephaly in a systematic review and meta-analysis. BMC Public Health 20, 827 (2020).
França, G. V. A. et al. Congenital Zika virus syndrome in Brazil: a case series of the first 1501 livebirths with complete investigation. Lancet 388, 891–897 (2016).
Pomar, L. et al. Association between Zika virus and fetopathy: a prospective cohort study in French Guiana. Ultrasound Obstet. Gynecol. 49, 729–736 (2017).
Delatorre, E., Fernández, J. & Bello, G. Investigating the role of Easter Island in migration of Zika virus from South Pacific to Americas. Emerg. Infect. Dis. 24, 2119–2121 (2018).
Ferguson, N. M. et al. Countering the Zika epidemic in Latin America. Science 353, 353–354 (2016).
Parker, D. M. et al. High Seroprevalence to Aedes-borne arboviruses in Ethiopia: a cross-sectional survey in 2024. https://doi.org/10.1101/2024.09.19.24313917 (2024).
Gobillot, T. A. et al. Zika virus circulates at low levels in Western and Coastal Kenya. J. Infect. Dis. 222, 847–852 (2020).
Fourié, T., Grard, G., Leparc-Goffart, I., Briolant, S. & Fontaine, A. Variability of Zika virus incubation period in humans. Open Forum Infect. Dis. 5, ofy261 (2018).
Zika: data and analysis. Pan American Health Organization https://www.paho.org/en/arbo-portal/zika-data-and-analysis/ (2025).
Pathogen Epidemiology Review Group. Priority pathogens: wiki. https://github.com/mrc-ide/priority-pathogens/wiki/ (2025).
Covidence systematic review software. (Covidence, 2025) https://www.covidence.org/
Fitzjohn, R. et al. orderly2: orderly next generation. https://github.com/mrc-ide/orderly2 (2025).
Schwarzer, G. meta: General package for meta-analysis. R version 8.2-1 https://cran.r-project.org/web/packages/meta/index.html (2025).
Nash, R. et al. mrc-ide/priority-pathogens: Zika revisions release. Zenodo https://doi.org/10.5281/zenodo.17201039 (2025).
Countries and territories with current or previous Zika virus transmission, by WHO regional office. (World Health Organization, accessed 7 June 2025); https://cdn.who.int/media/docs/default-source/documents/emergencies/zika/countries-with-zika-and-vectors-table_february-2022.pdf?sfvrsn=4dc1f8ab_5
GADM database of Global Administrative Areas. (GADM, accessed 13 May, 2025); https://gadm.org/ (2025).
Armstrong, P. M. et al. Successive blood meals enhance virus dissemination within mosquitoes and increase transmission potential. Nat. Microbiol. 5, 239–247 (2020).
Champagne, C. et al. Structure in the variability of the basic reproductive number (R0) for Zika epidemics in the Pacific islands. eLife 5, e19874 (2016).
Guo, X. et al. Vector competence and vertical transmission of Zika virus in Aedes albopictus (Diptera: Culicidae). Vector Borne Zoonotic Dis 20, 374–379 (2020).
Hugo, L. E. et al. Vector competence of Australian Aedes aegypti and Aedes albopictus for an epidemic strain of Zika virus. PLoS Negl. Trop. Dis. 13, e0007281 (2019).
Kucharski, A. J. et al. Transmission dynamics of Zika virus in island populations: a modelling analysis of the 2013–14 French Polynesia outbreak. PLoS Negl. Trop. Dis. 10, e0004726 (2016).
Ryckebusch, F., Berthet, M., Missé, D. & Choumet, V. Infection of a French population of Aedes albopictus and of Aedes aegypti (Paea Strain) with Zika virus reveals low transmission rates to these vectors’ Saliva. Int. J. Mol. Sci. 18, 2384 (2017).
Shutt, D. P., Manore, C. A., Pankavich, S., Porter, A. T. & Del Valle, S. Y. Estimating the reproductive number, total outbreak size, and reporting rates for Zika epidemics in South and Central America. Epidemics 21, 63–79 (2017).
Winokur, O. C., Main, B. J., Nicholson, J. & Barker, C. M. Impact of temperature on the extrinsic incubation period of Zika virus in Aedes aegypti. PLoS Negl. Trop. Dis. 14, e0008047 (2020).
Zimler, R. A. & Alto, B. W. The extrinsic incubation period of Zika virus in Florida mosquitoes Aedes aegypti and Ae. albopictus. Pathogens 10, 1252 (2021).
Abtibol-Bernardino, M. R. et al. Would Zika virus infection in pregnancy be a sentence of poor neurological prognosis for exposed children? Neurodevelopmental outcomes in a cohort from Brazilian Amazon. Viruses 14, 2659 (2022).
Alger, J. et al. Microcephaly outcomes among Zika virus–infected pregnant women in Honduras. Am. J. Trop. Med. Hyg. 104, 1737–1740 (2021).
Alvarado-Domenech, L. I. et al. Early childhood neurodevelopmental outcomes in children with prenatal Zika virus exposure: a cohort study in Puerto Rico. J. Pediatr. 247, 38–45.e5 (2022).
Aromolaran, A. et al. Unequal burden of Zika-associated microcephaly among populations with public and private healthcare in Salvador, Brazil. Int. J. Infect. Dis. 120, 201–204 (2022).
Brasil, P. et al. Zika virus infection in pregnant women in Rio de Janeiro. N. Engl. J. Med. 375, 2321–2334 (2016).
Brasil, P. et al. Zika virus vertical transmission in children with confirmed antenatal exposure. Nat. Commun. 11, 3510 (2020).
Cranston, J. S. et al. Association between antenatal exposure to Zika virus and anatomical and neurodevelopmental abnormalities in children. JAMA Netw. Open 3, e209303 (2020).
De Melo Espindola, O. et al. ZIKA virus neutralizing antibody kinetics in antenatally exposed infants. J. Infect. Dis. 224, 1060–1068 (2021).
de Sousa, I. B. A. et al. Gestational outcomes in women infected by Zika virus during pregnancy in Mato Grosso do Sul, Brazil: a cross-sectional study. Int. J. Infect. Dis. 98, 359–365 (2020).
Grant, R. et al. Maternal and neonatal outcomes related to Zika virus in pregnant women in Southern Vietnam: an epidemiological and virological prospective analysis. Lancet Reg. Health West. Pac. 11, 100163 (2021).
Grant, R. et al. Consequences of in utero Zika virus exposure and adverse pregnancy and early childhood outcomes: a prospective cohort study. Viruses 14, 2755 (2022).
Gutiérrez-Sánchez, L. Á. et al. Fetal central nervous system anomalies according to RT-PCR and trimester of maternal infection with Zika virus: a prospective cohort study. Acta Obstet. Gynecol. Scand. 101, 221–231 (2022).
Hcini, N. et al. Association between confirmed congenital Zika infection at birth and outcomes up to 3 years of life. Nat. Commun. 12, 3270 (2021).
Honein, M. A. et al. Birth defects among fetuses and infants of US women with evidence of possible Zika virus infection during pregnancy. JAMA 317, 59–68 (2017).
Lee, E. H. et al. First 12 Months of life for infants in New York City, New York, with possible congenital Zika virus exposure. J. Pediatr. Infect. Dis. Soc. 9, 311–319 (2020).
Martínez-Arias, A. et al. Zika virus screening during pregnancy: results and lessons learned from a screening program and a post-delivery follow-up analysis (2016–2022). Birth Defects Res. 115, 1646–1657 (2023).
Martins, R. S. et al. The role of pregnant women with rash in the Zika virus sentinel surveillance. Rev. Soc. Bras. Med. Trop. 52, e20180351 (2019).
Merriam, A. A., Nhan-Chang, C.-L., Huerta-Bogdan, B. I., Wapner, R. & Gyamfi-Bannerman, C. A single-center experience with a pregnant immigrant population and Zika virus serologic screening in New York City. Am. J. Perinatol. 37, 731–737 (2020).
Moore, S. M. et al. Leveraging multiple data types to estimate the size of the Zika epidemic in the Americas. PLoS Negl. Trop. Dis. 14, e0008640 (2020).
Osoro, E. et al. Prevalence of microcephaly and Zika virus infection in a pregnancy cohort in Kenya, 2017–2019. BMC Med. 20, 291 (2022).
Pacheco, O. et al. Zika virus disease in Colombia—preliminary report. N. Engl. J. Med. 383, e44 (2020).
Pereira, J. P. et al. Association of prenatal ultrasonographic findings with adverse neonatal outcomes among pregnant women with Zika virus infection in Brazil. JAMA Netw. Open 1, e186529–e186529 (2018).
Pimentel, R. et al. Birth defects and long-term neurodevelopmental abnormalities in infants born during the Zika virus epidemic in the Dominican Republic. Ann. Glob. Health 87, 4 (2021).
Pool, K.-L. et al. Association between neonatal neuroimaging and clinical outcomes in Zika-exposed infants from Rio de Janeiro, Brazil. JAMA Netw. Open 2, e198124–e198124 (2019).
Robbiani, D. F. et al. Risk of Zika microcephaly correlates with features of maternal antibodies. J. Exp. Med. 216, 2302–2315 (2019).
Rodrigues, Md. S. P. et al. Repercussions of Zika virus emergency on the health of the population of Tocantins state, Brazil, 2015 and 2016: a descriptive study. Epidemiol. Serv. Saude 29, e2020096 (2020).
Rosado, L. E. P. et al. Risk of adverse pregnancy and infant outcomes associated with prenatal Zika virus infection: a post-epidemic cohort in Central-West Brazil. Sci. Rep. 13, 7335 (2023).
Sanchez Clemente, N. et al. Can Zika virus infection in high risk pregnant women be differentiated on the basis of symptoms? Viruses 12, 1263 (2020).
Soriano-Arandes, A. et al. Clinical outcomes of a Zika virus mother–child pair cohort in Spain. Pathogens 9, 352 (2020).
Tannis, A. et al. Birth outcomes related to prenatal Zika, Dengue, and other flavivirus infections in the Zika en Embarazadas y Niños Prospective Cohort Study in Colombia. Am. J. Trop. Med. Hyg. 111, 622 (2024).
Tozetto-Mendoza, T. R. et al. Zika virus infection among symptomatic patients from two healthcare centers in Sao Paulo State, Brazil: prevalence, clinical characteristics, viral detection in body fluids and serodynamics. Rev. Inst. Med. Trop. Sao Paulo 61, e19 (2019).
Ximenes, R. A. d. A. et al. Zika-related adverse outcomes in a cohort of pregnant women with rash in Pernambuco, Brazil. PLoS Negl. Trop. Dis. 15, e0009216 (2021).
